Considerations of HAV vaccine in India.

Simple item page
dc.contributor.authorMathur, Pen_US
dc.contributor.authorArora, N Ken_US
dc.date.accessioned1999-01-08en_US
dc.date.accessioned2009-05-30T15:23:21Z
dc.date.available1999-01-08en_US
dc.date.available2009-05-30T15:23:21Z
dc.date.issued1999-01-08en_US
dc.description40 references.en_US
dc.description.abstractCurrently available evidence indicates that most parts of India still quality to be hyper-endemic regions and hence recommendations for vaccinations developed for low endemicity regions are not applicable. There are however, some pockets which showed evidence of distinct epidemiologic shift. There is need to identify geographic regions like Kerala which have potential for epidemic outbreaks through cyclic sero-epidemiological surveys. With economic development and consequent improvements in the levels of sanitation and quality of water supplies, more such areas will be identified. Efforts to improve sanitation and personal hygiene will remain as the most important and efficient intervention to retard the transmission of HAV. Unless a critical improvement in the living standards of our population is achieved, aim of eradicating HAV infection from the community is not realistic. Presently, the cost of three doses of HAV is exorbitant and the focus of HAV vaccination will have to be restricted to individual protection who are likely to remain unexposed till adulthood and can afford to pay for it. HAV Infection below 5 years is mostly asymptomatic. The most efficient use of resources will therefore be to offer HAV vaccine to high risk individuals beyond this age after screening for antibodies against HAV.en_US
dc.description.affiliationDepartment of Pediatrics, AIIMS, New Delhi.en_US
dc.identifier.citationMathur P, Arora NK. Considerations of HAV vaccine in India. Indian Journal of Pediatrics. 1999 Jan-Feb; 66(1): 111-20en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/83574
dc.language.isoengen_US
dc.source.urihttps://medind.nic.in/icb/icbai.shtmlen_US
dc.subject.meshAdulten_US
dc.subject.meshChilden_US
dc.subject.meshHepatitis A --economicsen_US
dc.subject.meshHumansen_US
dc.subject.meshIndia --epidemiologyen_US
dc.subject.meshRisk Factorsen_US
dc.subject.meshSeroepidemiologic Studiesen_US
dc.subject.meshViral Hepatitis Vaccines --economicsen_US
dc.titleConsiderations of HAV vaccine in India.en_US
dc.typeJournal Articleen_US
dc.typeReviewen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Journal of Pediatrics